-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In order to further protect the safety of public medication, the National Medical Products Administration has decided to treat paracetamol and acetaminophen, acetaminophen and acetaminophen syrup, pediatric paracetamol granules, paracetamol and pseudoephedrine chewable tablets, pediatric compound paracetamol tablets, and pediatric ammonia Kahuangmin Granules, Aminojinjinmin Granules, Aminocayumin Solution, Children's Compound Paracetamol and Renin Tablets, Aminocahuangmin Oral Solution, Paracetamol and Pseudoephedrine Dispersible Tablets (Ⅲ), Pediatric Paracetamol and Namin Tablets, Pediatric The drug inserts of 14 varieties including Paracetamol Huang Namin Tablets and Pediatric Paracetamol Huang Namin Granules were revised
1.
If the revised content involves the label of a drug, it shall be revised together; the instructions and other content of the label shall be consistent with the original approved content
2.
3.
4.
5.
Hereby announce
Attachment: Requirements for revision of drug inserts for 14 varieties including paracetamol Asami oral solution
State Food and Drug Administration
April 21, 2021